Biden DOJ Files To Pause Judge’s Block On Abortion Pill FDA Approval: ‘Extraordinary And Unprecedented’

The Daily Caller

Biden DOJ Files To Pause Judge’s Block On Abortion Pill FDA Approval: ‘Extraordinary And Unprecedented’

Katelynn Richardson on April 10, 2023

The Biden administration filed an emergency motion Monday to stay a federal judge’s decision to suspend the Food and Drug Administration’s (FDA) approval of the abortion pill.

Biden’s Department of Justice (DOJ) filed its motion Monday with the Fifth Circuit Court of Appeals, calling the block on the pill’s approval an “extraordinary and unprecedented” decision that would “thwart FDA’s scientific judgment and severely harm women.” The DOJ already filed a notice of appeal Friday shortly after U.S. District Court Judge Matthew Kacsmaryk of Texas issued a preliminary injunction that halted the FDA’s approval of mifepristone, the first of two drugs used in a chemical abortion.


“This harm would be felt throughout the country, given that mifepristone has lawful uses in every State,” the DOJ wrote in its motion. “The order would undermine healthcare systems and the reliance interests of businesses and medical providers.”

The injunction’s seven-day administrative stay, which the judge gave to allow time for appeal, should be extended until the case is resolved, the DOJ argued. It asked for a decision by noon on April 13 so the government can “seek relief in the Supreme Court if necessary.”

“In September 2000, FDA abandoned its safety proposals and acquiesced to the objections of the Population Council and Danco,” Kacsmaryk wrote in his Friday ruling. “Despite its ‘serious reservations’ about mifepristone’s safety, FDA approved a regimen that relied on a self-certification that a prescribing physician has the ability to diagnose ectopic pregnancies.”

Earlier today, the DOJ also requested clarification from the Eastern District of Washington court, which issued a conflicting ruling on Friday prohibiting the FDA from “altering the status quo and rights as it relates to the availability of Mifepristone.”

“The Court did not address the interaction between the two orders, presumably because they were issued less than 20 minutes apart,” the filing states.

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].

You appear to be using an ad blocker

Shore News Network is a free website that does not use paywalls or charge for access to original, breaking news content. In order to provide this free service, we rely on advertisements. Please support our journalism by disabling your ad blocker for this website.